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Introduction 
        Raynaud’s phenomenon (RP) is a 
widely prevalent clinical disorder 
commonly seen in outpatient settings. It 
is characterized by episodic vasospastic 
attacks of the digital arteries and 
arterioles that limit blood flow to the 
extremities, causing severe pain. 
Temperature changes and stress are the 
primary triggers that exacerbate this 
disease. The classic biphasic color 
changes of RP are pallor, cyanosis, and 
erythema and commonly affect the 
fingers and toes and more rarely, the 
nose, nipples, ears, lips, and penis. RP is 
divided into subcategories. Primary 
Raynaud’s phenomenon (PRP) is when 
no underlying medical disease exists and 
the condition happens spontaneously. It 
is usually benign with mild attacks and 
treated with conservative measures. 
Secondary Raynaud’s phenomenon 
(SRP) occurs in the context of an 
underlying systemic disease such as 
Scleroderma (Brown, 2012, p. 41). SRP 
patients often experience more severe 
attacks and require pharmacological 
treatments along with conservative 
measures. They are at greater risk of 
developing more severe symptoms such 
as digital ulcerations and gangrene 
(Parker, 2013, p. 23).  
 
        An increased understanding of the 
pathophysiology of PRP and SRP has 
enhanced the treatment options 
available for these patients. Although RP 
can poses problematic, debilitating 
symptoms for patients, healthcare 
professionals can help these patients 
learn how to self-manage their disease 
and live a more comfortable lifestyle. 
This topic was chosen to research to 
increase nurses’ knowledge of the 
pathophysiology of PRP and SRP, the 
presentation of the disease symptoms,  
and the implications that the care 
provided can have on patient outcomes.  
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 Signs and Symptoms         
 
        The signs and symptoms of RP depend on the severity and frequency of the 
vasospastic attacks. Symptoms associated with this disease include the following: 
 
• Numbness 
• Pain 
• Paraesthesia 
 
        Cold temperatures or emotional stressors trigger an attack and the blood supply 
to the body’s extremities is temporarily ceased due to vasoconstriction, causing pain 
and numbness (Mawdsley, 2011, p. 130). Paraesthesia occurs when the blood flow is 
restored to these extremities. The following signs are associated with this disease 
are known as the classic biphasic color changes.  
 
 Pallor (white) 
 Cyanosis (blue) 
 Erythema (red) 
 
        First, a whitening (pallor) of the extremities affected (usually the fingers or toes) 
occurs due to ischemia from vasoconstriction, followed by a blue (cyanosis) color 
due to the lack of oxygen, and resolving with a red (erythema) flushed color 
representing reperfusion to the digits affected. Signs and symptoms usually resolve 
within one hour if appropriate interventions are utilized. Other symptoms 
associated more commonly with SRP are digital ulcerations, gangrene, skin thinning, 
tightening, sclerodactyly, and telangiectasias (Valdovinos & Landry, 2014, p.242). 
The figure below shows the classic biphasic color changes associated with RP (“Cold 
fingers,” 2009, p. 4). 
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  Underlying Pathophysiology  
 
        Although the pathophysiology of RP is still being explored, much has been 
uncovered from extensive research. The main concept is impaired perfusion to the 
peripheral parts of extremities triggered by cold temperatures and emotional 
stressors which in turn causes reversible, vasospastic attacks. In both forms of RP, 
the triggers lead to vasoconstriction and vasospasms. Clinically, first the affected 
digits become white (pallor) due to the decrease in blood flow and then progress to 
a blue (cyanotic) color due to deoxygenation and finally turn a flushed red 
(erythema) color to represent reperfusion to the affected digit after rewarming 
interventions have been successful (Polidoro et al., 2012, p. 532). PRP manifests 
with symmetric symptoms, usually a milder form in which the thumb is not affected 
whereas SRP may have unilateral symptoms with more severe, debilitating 
complications such as digital ulcerations. When the thumb is affected, this indicates 
SRP and that an underlying connective tissue disease is probable. The following 
table displays the important distinctions between PRP and SRP (Devulder et al., 
2011, p. 485). 
  
       
 
 
 
 
 
 
 
   
 
        During an episode there is sustained vasoconstriction with impaired 
vasodilation, endothelial dysfunction, and platelet activation and aggregation (Vacca, 
2014, p. 58). Vasoconstriction occurs as a response to triggers in the small muscular 
arteries and arterioles in the digits affected. PRP is thought to be related to 
abnormal vasoconstriction of digital arteries and cutaneous arterioles due to a local 
functional defects in normal vascular responses. Evidence suggest that the defect is 
an increase in alpha-2 adrenergic responses in the digital and cutaneous vessels that 
causes arterial vasoconstriction which leads to vasospasms (Vacca, 2014, p. 58). 
Capillary damage prevents the endothelium from releasing vasodilating substances 
such as nitric oxide, prostaglandins, and neuropeptides, which further sustains 
vasoconstriction (Vacca, 2014, p. 58). Nitric Oxide inhibits vascular smooth muscle 
contraction, platelet aggregation and adhesions of platelets. With the impaired 
release of nitric oxide and other vasodilating substance, vasoconstriction and 
vasospasm persist. Furthermore, platelet activation and aggregation causes 
endothelial cell dysfunction and activates the release of endogenous 
vasoconstrictors, thus continuing to lead to sustained vasoconstriction and 
vasospasms (Polidoro et al., 2012, p. 532). 
        The underlying disease associated with SRP is thought to disrupt the normal 
mechanisms responsible for the control of vessel reactivity. Structural vascular 
changes occur with SRP. The arterial lumen narrows due to adventitial fibrosis, 
intimal proliferation and fibrosis, causing more severe symptoms which can lead to 
tissue ischemia (Sinnathurai & Schrieber, 2013, p. 478). Recurrent episodes of 
ischemia and reperfusion from SRP can lead to significant complications and 
morbidity.  
Epidemiology 
 
RP occurs more frequently in woman than in men with an onset median age of 14 
and 27% of people presenting with the disease for the first time are 40 years or older 
(Brown, 2012, p. 42). The majority of women have PRP (85%) while 15% have SRP, 
whereas in men the incidence of the two types are equal (Brown, 2012, p. 42). 
Worldwide, the incidence of RP in adults is 4% to 20% and about 5% to 10% of all 
Americans (Vacca, 2014, p. 58). Non-modifiable risk factors associated with RP include 
being a female gender and having a family history of the disease. Modifiable risk 
factors include occupational use of vibrating tools, taking medications such as beta 
blockers or amphetamines, smoking, and underlying conditions such as 
atherosclerosis, hypothyroidism, polycythemia, and other hyperviscosity states. 
 
 
 
Those patients suffering from RP may have a diminished quality of life due to 
their signs and symptoms from the disease. They can also be at high risk for 
developing life-altering complications, especially those with SRP. The primary 
goals of therapy are to improve the quality of life of patients, reduce the 
frequency and intensity of vasospastic attacks, and to prevent ischemic tissue 
injury. Understanding the mechanisms involved in the pathophysiology of this 
disease process is the key to providing goal directed therapy and will allow 
healthcare professionals to better educate their patients while providing them 
with a better quality of life. 
 
 
RP is an exaggerated vascular response to cold temperatures or to emotional 
stress, which is characterized by the classic biphasic color changes, pallor, cyanosis, 
and erythema, in affected digits. In PRP, symptoms occur without an underlying 
disease and treatment is focused more on conservative measures due to milder 
attacks. SRP occurs in association with another disease such as an autoimmune 
disease and symptoms are more severe usually requiring conservative and 
pharmacological treatments. Understanding the pathophysiology of this disease 
process will help APNs diagnosis this phenomenon more definitively and better 
direct treatment goals to improving ones quality of life. 
 
 
Conclusion 
        Advanced practice nurses (APN) must complete a full thorough history and 
physical exam to diagnose RP and must be able to differentiate between PRP and 
SRP. A careful history should include the age of onset, affected digits, and degree of 
severity, frequency, and symmetry of attacks. The following three screening 
questions should be asked to all patients with suspected RP (Wigley, 2015, p.12): 
 
• Are your fingers usually sensitive to cold? 
• Do your fingers change color when they are exposed to cold temperatures? 
• Do your fingers turn white, blue, or both? 
 
        If the patient has positive answers to all three questions then a diagnosis of RP 
is usually made but then the APN has to inspect deeper to figure out the cause. The 
APN should ask the patient about potential exposures or aggravating factors such as 
occupational risks (frostbite, hand-arm vibration), medications (nicotine, non-
selective beta-blockers), and neurological conditions (carpal tunnel syndrome). A 
complete physical assessment should be conducted to evaluate for other symptoms 
of a suggestive autoimmune disease such as fever, skin rashes, and 
cardiopulmonary and musculoskeletal abnormalities. The fingers and toes should 
especially be inspected for signs of tissue ischemia, as these are the most common 
digits affected. Lastly, nailfold capillaroscopy is a preferred method to distinguish 
between PRP and SRP. Patients with normal capillary loops around the nail bed 
have PRP whereas the capillary loops around the nails bed in SRP can be enlarged, 
disorganized, and may even hemorrhage (Brown, 2012, p. 42).  
  
        Once the diagnosis of RP has been made, either PRP or SRP, the APN must 
determine the severity of the disease process. It is vital to have a definitive 
diagnosis so that proper treatment measures can be effective. The APN must direct 
nursing care at preventing complications and improving the quality of life for their 
patients. The following are common conservative measures to prevent attacks: 
 
• Avoid cold exposure 
• Avoid rapidly changing temperatures 
• Use strategies to keep the entire body warm 
• Avoid cigarette smoke 
• Exercise 
• Manage stress with relaxation techniques and meditation 
• Have knowledge on methods to help terminate an attack 
 
        Encouraging patients to develop self-management strategies helps patients 
establish a sense of empowerment. An important aspect of the management for RP 
is recognizing triggers and knowing how to prevent exacerbations. APNs need to 
provide support for their patients as they will be making lifestyle changes. Having a 
compassionate and caring healthcare team influences the patient to make healthy 
lifestyle changes and promotes a better well-being while decreasing stress. 
Significance of Pathophysiology 
